|
1
|
Bo J, Yang G, Huo K, Jiang H, Zhang L, Liu
D and Huang Y: microRNA-203 suppresses bladder cancer development
by repressing bcl-w expression. FEBS J. 278:786–792. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ben-Dor I, Bern O, Tennenbaum T and Nir U:
Cell cycle-dependent nuclear accumulation of the p94fer tyrosine
kinase is regulated by its NH2 terminus and is affected by kinase
domain integrity and ATP binding. Cell Growth Differ. 10:113–129.
1999.PubMed/NCBI
|
|
4
|
Miyata Y, Kanda S, Sakai H and Greer PA:
Feline sarcoma-related protein expression correlates with malignant
aggressiveness and poor prognosis in renal cell carcinoma. Cancer
Sci. 104:681–686. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li H, Ren Z, Kang X, Zhang L, Li X, Wang
Y, Xue T, Shen Y and Liu Y: Identification of
tyrosine-phosphorylated proteins associated with metastasis and
functional analysis of FER in human hepatocellular carcinoma cells.
BMC Cancer. 9:3662009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zoubeidi A, Rocha J, Zouanat FZ, Hamel L,
Scarlata E, Aprikian AG and Chevalier S: The Fer tyrosine kinase
cooperates with interleukin-6 to activate signal transducer and
activator of transcription 3 and promote human prostate cancer cell
growth. Mol Cancer Res. 7:142–155. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Albeck JG and Brugge JS: Uncovering a
tumor suppressor for triple-negative breast cancers. Cell.
144:638–640. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Allard P, Zoubeidi A, Nguyen LT, Tessier
S, Tanguay S, Chevrette M, Aprikian A and Chevalier S: Links
between Fer tyrosine kinase expression levels and prostate cell
proliferation. Mol Cell Endocrinol. 159:63–77. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stetler-Stevenson WG and Yu AE: Proteases
in invasion: Matrix metalloproteinases. Semin Cancer Biol.
11:143–152. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Batlle E, Sancho E, Francí C, Domínguez D,
Monfar M, Baulida J and De Herreros A García: The transcription
factor snail is a repressor of E-cadherin gene expression in
epithelial tumour cells. Nat Cell Biol. 2:84–99. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bolós V, Peinado H, Pérez-Moreno MA, Fraga
MF, Esteller M and Cano A: The transcription factor slug represses
E-cadherin expression and induces epithelial to mesenchymal
transitions: A comparison with Snail and E47 repressors. J Cell
Sci. 116:499–511. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sebolt-Leopold JS and Herrera R: Targeting
the mitogen-activated protein kinase cascade to treat cancer. Nat
Rev Cancer. 4:937–947. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Angel P and Karin M: The role of Jun, Fos
and the AP-1 complex in cell-proliferation and transformation.
Biochim Biophys Acta. 1072:129–157. 1991.PubMed/NCBI
|
|
16
|
Raman M, Chen W and Cobb MH: Differential
regulation and properties of MAPKs. Oncogene. 26:3100–3112. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sobin DH and Wittekind C: TNM
Classification of Malignant Tumors. 6th. Wiley-Liss; New York, NY:
2003, View Article : Google Scholar
|
|
18
|
Miyamoto H, Miller JS, Fajardo DA, Lee TK,
Netto GJ and Epstein JI: Non-invasive papillary urothelial
neoplasms: The 2004 WHO/ISUP classification system. Pathol Int.
60:1–8. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Groblewska M, Siewko M, Mroczko B and
Szmitkowski M: The role of matrix metalloproteinases (MMPs) and
their inhibitors (TIMPs) in the development of esophageal cancer.
Folia Histochem Cytobiol. 50:12–19. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hao QL, Heisterkamp N and Groffen J:
Isolation and sequence analysis of a novel human tyrosine kinase
gene. Mol Cell Biol. 9:1587–1593. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Orlovsky K, Theodor L, Malovani H, Chowers
Y and Nir U: Gamma interferon down-regulates Fer and induces its
association with inactive Stat3 in colon carcinoma cells. Oncogene.
21:4997–5001. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ahn J, Truesdell P, Meens J, Kadish C,
Yang X, Boag AH and Craig AW: Fer protein-tyrosine kinase promotes
lung adenocarcinoma cell invasion and tumor metastasis. Mol Cancer
Res. 11:952–963. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Moss LA Shuman, Jensen-Taubman S and
Stetler-Stevenson WG: Matrix metalloproteinases: Changing roles in
tumor progression and metastasis. Am J Pathol. 181:1895–1899. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Scheel C, Onder T, Karnoub A and Weinberg
RA: Adaptation versus selection: The origins of metastatic
behavior. Cancer Res. 67:11476–11479; discussion 11479–11480. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Craig AW and Greer PA: Fer kinase is
required for sustained p38 kinase activation and maximal chemotaxis
of activated mast cells. Mol Cell Biol. 22:6363–6374. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kogata N, Masuda M, Kamioka Y, Yamagishi
A, Endo A, Okada M and Mochizuki N: Identification of Fer tyrosine
kinase localized on microtubules as a platelet endothelial cell
adhesion molecule-1 phosphorylating kinase in vascular endothelial
cells. Mol Biol Cell. 14:3553–3564. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Piedra J, Miravet S, Castaño J, Pálmer HG,
Heisterkamp N, de Herreros A García and Duñach M: p120
Catenin-associated Fer and Fyn tyrosine kinases regulate
beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin
interaction. Mol Cell Biol. 23:2287–2297. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Senis YA, Sangrar W, Zirngibl RA, Craig
AW, Lee DH and Greer PA: Fps/Fes and Fer non-receptor
protein-tyrosine kinases regulate collagen- and ADP-induced
platelet aggregation. J Thromb Haemost. 1:1062–1070. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cano A, Pérez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu AN, Zhu ZH, Chang SJ and Hang XS:
Twist expression associated with the epithelial-mesenchymal
transition in gastric cancer. Mol Cell Biochem. 367:195–203. 2012.
View Article : Google Scholar : PubMed/NCBI
|
